TFX (Teleflex) Long-Term Debt: $2,514 Mil (As of Mar. 2026)


TFX Teleflex Inc TFX
75 GF Score
Price $134.32
GF Value $181.17
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Teleflex Long-Term Debt?

Teleflex TFX +0.25% 75 Long-Term Debt is $2,514 Mil as of Mar. 2026. GuruFocus rates TFX with a GF Score™ of 75/100 and a GF Value™ of $181.17 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Teleflex's Long-Term Debt for the quarter that ended in Mar. 2026 was $2,514 Mil.

Teleflex's quarterly Long-Term Debt declined from Sep. 2025 ($2,572 Mil) to Dec. 2025 ($2,541 Mil) and declined from Dec. 2025 ($2,541 Mil) to Mar. 2026 ($2,514 Mil).

Teleflex's annual Long-Term Debt declined from Dec. 2023 ($1,728 Mil) to Dec. 2024 ($1,556 Mil) but then increased from Dec. 2024 ($1,556 Mil) to Dec. 2025 ($2,541 Mil).

Teleflex  (NYSE:TFX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Teleflex Long-Term Debt Related Terms

Teleflex Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Teleflex's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teleflex Long-Term Debt Chart

Teleflex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,740.10 1,624.02 1,727.57 1,555.87 2,541.45

Teleflex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,807.32 1,801.65 2,571.50 2,541.45 2,514.27
TFX
75GF Score
Teleflex Inc TFX
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $2,514 Mil mean?
Teleflex (TFX) has a Long-Term Debt of $2,514 Mil as of Mar. 2026.
Is Teleflex's Long-Term Debt too high?
Teleflex's current Long-Term Debt is $2,514 Mil. Overall, Teleflex has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Teleflex's Long-Term Debt compare to STVN and AVTR?
Teleflex's Long-Term Debt of $2,514 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Teleflex's current Long-Term Debt is $2,514 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teleflex stock overvalued right now?
Based on GuruFocus' analysis, Teleflex (TFX) is currently considered Modestly Undervalued. The stock's GF Value™ is $181.17, compared to a current price of $134.32 — trading 25.9% below its estimated fair value. The current Long-Term Debt is $2,514 Mil. Teleflex's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Teleflex (TFX), the current Long-Term Debt is $2,514 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teleflex (TFX) Overvalued in 2026?

Based on GuruFocus' analysis, Teleflex stock appears to be undervalued. The current stock price of $134.32 is trading 25.9% below its estimated GF Value™ of $181.17. GuruFocus considers Teleflex to be Modestly Undervalued.

Key valuation signals for TFX:

  • Long-Term Debt: $2,514 Mil
  • GF Value™: $181.17 vs. price of $134.32 (25.9% below fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the TFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Teleflex Business Description

Other Exchanges 1TFX:ItalyTBH:Germany
Address 550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
75GF Score

Get the complete analysis for TFX

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$134.32
Price
$181.17
GF Value